BRAF <sup>V600</sup> and ErbB inhibitors directly activate GCN2 in an off-target manner to limit cancer cell proliferation

C. Ryland Ill(University of Colorado Boulder), Sabrina L. Spencer(University of Colorado Boulder)
bioRxiv (Cold Spring Harbor Laboratory)
December 20, 2024
Cited by 2


Related Papers